Your browser doesn't support javascript.
loading
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.
Kho, Pik-Fang; Amant, Frederic; Annibali, Daniela; Ashton, Katie; Attia, John; Auer, Paul L; Beckmann, Matthias W; Black, Amanda; Brinton, Louise; Buchanan, Daniel D; Chanock, Stephen J; Chen, Chu; Chen, Maxine M; Cheng, Timothy H T; Cook, Linda S; Crous-Bous, Marta; Czene, Kamila; De Vivo, Immaculata; Dennis, Joe; Dörk, Thilo; Dowdy, Sean C; Dunning, Alison M; Dürst, Matthias; Easton, Douglas F; Ekici, Arif B; Fasching, Peter A; Fridley, Brooke L; Friedenreich, Christine M; García-Closas, Montserrat; Gaudet, Mia M; Giles, Graham G; Goode, Ellen L; Gorman, Maggie; Haiman, Christopher A; Hall, Per; Hankinson, Susan E; Hein, Alexander; Hillemanns, Peter; Hodgson, Shirley; Hoivik, Erling A; Holliday, Elizabeth G; Hunter, David J; Jones, Angela; Kraft, Peter; Krakstad, Camilla; Lambrechts, Diether; Le Marchand, Loic; Liang, Xiaolin; Lindblom, Annika; Lissowska, Jolanta.
Afiliación
  • Kho PF; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Amant F; School of Biomedical Science, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Annibali D; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
  • Ashton K; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
  • Attia J; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Auer PL; Centre for Information Based Medicine, University of Newcastle, Callaghan, New South Wales, Australia.
  • Beckmann MW; Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia.
  • Black A; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Brinton L; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
  • Buchanan DD; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Chanock SJ; Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
  • Chen C; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Chen MM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Cheng THT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Cook LS; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Crous-Bous M; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Czene K; Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • De Vivo I; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Dennis J; Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Dörk T; Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Dowdy SC; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Dunning AM; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Dürst M; University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
  • Easton DF; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada.
  • Ekici AB; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Fasching PA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Fridley BL; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Friedenreich CM; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • García-Closas M; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Gaudet MM; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Giles GG; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Goode EL; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Gorman M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Haiman CA; Department of Gynaecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
  • Hall P; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Hankinson SE; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Hein A; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Hillemanns P; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Hodgson S; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, USA.
  • Hoivik EA; Department of Biostatistics, Kansas University Medical Center, Kansas City, Kansas, USA.
  • Holliday EG; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada.
  • Hunter DJ; Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Jones A; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia, USA.
  • Kraft P; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Krakstad C; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Lambrechts D; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Le Marchand L; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Liang X; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Lindblom A; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Lissowska J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Int J Cancer ; 148(2): 307-319, 2021 01 15.
Article en En | MEDLINE | ID: mdl-32851660
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triglicéridos / Neoplasias Endometriales / HDL-Colesterol / LDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Int J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triglicéridos / Neoplasias Endometriales / HDL-Colesterol / LDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Int J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Australia